Novel Treatments for Adolescent Vaping Cessation: Are We There Yet?

Authors

Jasleen Kaur, Connecticut Valley Hospital, CT, USAFollow
Amanda Rossi, Family Practice and Internal Medicine of New Haven, CT, USA
Sofia Adams, Hartford Hospital, Hartford, CT, USA
Mariginder Singh Varowal, Government Medical College, Amritsar, India
Lakshit Jain, University of Connecticut Health Center, Farmington, CT, USA
Mohsin Raza, UHS: Dover Behavioral Health System, Dover, DE, USA
Zouina Sarfraz, Fatima Jinnah Medical University, Lahore, PakistanFollow

Abstract

E-cigarette use among adolescents is a growing public health concern, driven by discreet designs, appealing flavors, and social influences. Despite high addiction rates, most teen users express a desire to quit, though evidence-based cessation tools remain limited. Behavioral interventions, including tech-based programs like This Is Quitting and smokeSCREEN, show promise. Pharmacotherapy, particularly varenicline, may support quitting, though its role in adolescents is still under investigation. Pediatricians must address this issue through empathetic, multifaceted approaches that combine education, behavioral support, and emerging treatments to curb early nicotine dependence and its long-term health consequences.

Recommended Citation

Kaur, Jasleen; Rossi, Amanda; Adams, Sofia; Varowal, Mariginder Singh; Jain, Lakshit; Raza, Mohsin; and Sarfraz, Zouina (2025) "Novel Treatments for Adolescent Vaping Cessation: Are We There Yet?," Journal of Community Hospital Internal Medicine Perspectives: Vol. 15: Iss. 5, Article 14.
DOI: 10.55729/2000-9666.1526
Available at: https://scholarlycommons.gbmc.org/jchimp/vol15/iss5/14

DOI

10.55729/2000-9666.1526